Yanping Xu

10PUBLICATIONS
33CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Chemical engineering designCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 12, 2026
Lactylation-Mediated HER2 Stabilization Promotes Trastuzumab Resistance in Gastric Cancer.

|Mar 25, 2026
AKT1 phosphorylates PRMT7 to promote GLUD1 methylation and gastric cancer progression.

Ziyi Cui, Hongchen Li, Xiaoben Liang

|Feb 06, 2025
Dimethyl fumarate promotes the degradation of HNF1B and suppresses the progression of clear cell renal cell carcinoma.

Yue Dai, Hongchen Li, Shiyin Fan

|Oct 16, 2023
D-mannose induces TFE3-dependent lysosomal degradation of EGFR and inhibits the progression of NSCLC.

Xue Sun, Yue Dai, Jing He

|Aug 07, 2023
TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential.

Jing He, Mingen Lin, Xinchao Zhang

|Mar 08, 2022
Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses.

Lei-Lei Chen, Carmen Morcelle, Zhou-Li Cheng

Pageof 2

Frequent Collaborators

6 joint publications

Lei Lv

3 joint publications

Hui Yang

2 joint publications

Qun-Ying Lei

2 joint publications

Tongguan Tian